The top public health officials during President Donald Trump's first term praised mRNA vaccines. In the second term, ...

(Reuters) -Vaxart said on Wednesday it received an order to stop work on screening and enrollment for its COVID-19 mid-stage ...

RNA drugs might be able to protect against a huge range of viruses by turning on key parts of our innate defences against ...

National Institutes of Health Director Jay Bhattacharya claims the federal government recently cancelled millions of dollars’ ...

Fox News senior medical analyst Dr. Marc Siegel reveals what he learned from his interview with National Institutes of Health ...

The Trump administration’s decision to halt nearly $500 million for mRNA vaccine research has made investors more hesitant to ...

Showing that his loyalty to his own anti-vax mentality is greater than his loyalty to President Donald Trump, Robert F.

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...

( NewsNation) — National Institutes of Health director Jay Bhattacharya believes mRNA vaccine technology is “promising” but ...

Scripps News speaks with vaccine experts who say HHS funding cuts targeting mRNA vaccines could hinder other vaccine research ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in treatment for cancers, rare disease and more.

Trump officials are capitalizing on lingering COVID resentment to undermine American vaccine policy.